NNC 13-8241

used as a radioligand for SPECT determination of benzodiazepine receptors

Also Known As:

(123)I-3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine; NNC-13-8241

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Brain Concussion (Cerebral Concussion) 11/01/2002 - "Images of 19 patients with mild traumatic brain injury who had received I NNC 13-8241 were compared with a mean brain template accumulated from 18 healthy volunteers. "
2.	Anxiety Disorders (Anxiety Disorder) 10/01/1997 - "We studied 10 drug-naive female patients with generalized anxiety disorder (GAD) and 10 age- and gender-matched healthy controls with MRI and with SPET by using a new (123)I-labelled specific benzodiazepine receptor radioligand, NNC 13-8241. "
3.	Traumatic Brain Injuries (Traumatic Brain Injury) 11/01/2002 - "Could automated template based quantification of benzodiazepine receptors in brain single photon emission tomography with 123I NNC 13-8241 be used to demonstrate neuronal damage in traumatic brain injury?"

1.	GABA-A Receptors (GABA(A) Receptor)